| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT04537871 Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study |
date change Primary completion pushed: 2026-06-30 -> 2027-05-25 |
| 2026-08-15 | NCT04537871 Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study |
date change Completion pushed: 2026-06-30 -> 2027-05-25 |
| 2026-08-15 | NCT07218718 Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane… |
Trial completed |
| 2026-08-15 | NCT07218718 Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane… |
Enrollment reduced: 60 -> 2 participants |
| 2026-08-15 | NCT07218718 Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane… |
date change Primary completion moved earlier: 2027-09-17 -> 2026-01-28 |
| 2026-08-15 | NCT07218718 Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane… |
date change Completion moved earlier: 2027-09-17 -> 2026-06-11 |
| 2026-08-14 | NCT04930653 Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic… |
critical Recruitment suspended |
| 2026-08-14 | NCT04930653 Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic… |
critical Recruitment suspended: Accrual Goal Met |
| 2026-08-14 | NCT05722288 Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or… |
date change Primary completion pushed: 2026-07-20 -> 2027-07-05 |
| 2026-08-14 | NCT05722288 Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or… |
date change Completion pushed: 2026-07-20 -> 2027-07-05 |
| 2026-08-13 | NCT07619599 A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among… |
Recruitment opened |
| 2026-08-12 | NCT04887805 Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of… |
date change Primary completion moved earlier: 2026-11-05 -> 2026-03-22 |
| 2026-08-11 | NCT07741968 A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic… |
Recruitment opened |
| 2026-08-11 | NCT07741968 A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic… |
Trial sites expanded: 2 -> 11 locations |
| 2026-08-06 | NCT02146924 Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia |
date change Primary completion pushed: 2026-07-15 -> 2027-06-17 |
| 2026-08-06 | NCT02146924 Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia |
date change Completion pushed: 2026-07-15 -> 2027-06-17 |
| 2026-08-06 | NCT03346135 Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma |
date change Primary completion pushed: 2026-07-01 -> 2027-05-17 |
| 2026-08-06 | NCT03346135 Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma |
date change Completion pushed: 2026-07-01 -> 2027-05-17 |
| 2026-08-06 | NCT04281199 TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients… |
date change Primary completion pushed: 2026-07-14 -> 2027-06-24 |
| 2026-08-06 | NCT04281199 TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients… |
date change Completion pushed: 2026-07-14 -> 2027-06-24 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07758673 Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or… | Phase 1 | Not Yet Recruiting |
| 2026-08-03 | NCT07741968 A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic… | Recruiting | |
| 2026-07-29 | NCT07733141 Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic… | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05376878 | An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| Phase 3 | |||
| NCT07186192 | Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen… | Hematologic Malignancies | Recruiting |
| NCT06763328 | Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT07271355 | Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of… | Metastatic Appendix Carcinoma | Not Yet Recruiting |
| NCT06169267 | Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone… | Hematopoietic and Lymphoid System Neoplasm | Active, Not Recruiting |
| NCT04428905 | Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal… | Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT04561206 | Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory… | Relapsed Classic Hodgkin Lymphoma | Recruiting |
| NCT06453044 | Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or… | Recurrent Grade 1 Follicular Lymphoma | Recruiting |
| NCT05869682 | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced… | Advanced Prostate Carcinoma | Recruiting |
| NCT06052826 | Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T… | B-Cell Non-Hodgkin Lymphoma | Recruiting |
| NCT06260033 | Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT06954831 | Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the… | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting |
| NCT06128070 | Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT04484012 | Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed… | Recurrent Mantle Cell Lymphoma | Recruiting |
| NCT04871607 | Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy… | Recurrent Hodgkin Lymphoma | Recruiting |
| NCT06731894 | Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in… | Breast Carcinoma | Recruiting |
| NCT06910761 | Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |
| NCT05830058 | Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06054776 | Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory… | Mantle Cell Lymphoma | Recruiting |
| NCT04734730 | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT07210086 | Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo… | Prostate Cancer | Recruiting |
| NCT06440850 | Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated… | Thyroid Gland Follicular Carcinoma | Recruiting |
| NCT07202247 | Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy… | Prostate Carcinoma | Recruiting |
| NCT05672108 | Phase II Trial of Lung Chemoemobolization | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06528990 | Telehealth Intervention for Ostomy Self-Management | Colorectal Cancer | Recruiting |